Table 1 Descriptive statistics and distribution of diagnoses for patients initially included in the population pharmacokinetic analysis.
From: Application of population pharmacokinetics to cladribine
Gender m/f | Age (years)2 | Weight (kg)2 | Height (cm)2 | BSA1 (m2)2 | ||
|---|---|---|---|---|---|---|
Total | 129/34 | 60 (13) [22–89] | 76 (14) [48–118] | 174 (9) [152–198] | 1.9 (0.2) [1.5–2.4] | |
Diagnosis | CLL | HCL | AML | NHL | CML | LCH |
Total | 63 | 84 | 3 | 7 | 4 | 2 |